You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 9, September 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Botulinum toxin for the treatment of hyperfunctional lines of the face

A. Blitzer, M. F. Brin, M. S. Keen and J. E. Aviv
Department of Otolaryngology, Columbia-Presbyterian Medical Center, New York, NY.

OBJECTIVE: To determine the effectiveness of botulinum toxin injections for the management of hyperfunctional facial lines in patients with dystonia. DESIGN: Twenty-six patients were included in the study: 24 patients had dystonic movement of the face as either a primary or secondary component, and two patients were treated for purely hyperfunctional lines. Botulinum toxin type A was injected via a monopolar hollow-bore Teflon-coated electromyography needle into the facial muscles associated with the hyperfunctional lines. Doses were divided into 1.25- to 10-U aliquots. Qualitative assessments by the patient and physician were made before injection and 2 to 3 weeks after injection. PATIENTS: Twenty-six patients (two male and 24 female) with hyperfunctional lines were included. The ages were from 32 to 84 years with an average age of 59 years. Twenty had dystonia, four had hemifacial spasm, and two had pure hyperfunction without neuromuscular disease. RESULTS: All of the patients had an effect of toxin within the first 24 to 72 hours. All of the patients experienced benefit from the toxin injections with partial or total resolution of painful contractions or unsightly hyperfunctional lines and spasms. The effects of the injection lasted 3 to 6 months. No systemic side effects were noted. Adverse effects included mild, temporary eyelid or lip weakness. CONCLUSION: Based on this initial pilot study, botulinum toxin may be an important new option for the treatment of patients with hyperfunctional facial lines.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Validated Rating Scale for Hyperkinetic Facial Lines
Kim et al.
Arch Facial Plast Surg 2004;6:253-256.
ABSTRACT | FULL TEXT  

Cosmetic Uses of Botulinum Neurotoxin Type A: An Overview
Blitzer and Binder
Arch Facial Plast Surg 2002;4:214-220.
FULL TEXT  

Effect of Botulinum Toxin Pretreatment on Laser Resurfacing Results: A Prospective, Randomized, Blinded Trial
Zimbler et al.
Arch Facial Plast Surg 2001;3:165-169.
ABSTRACT | FULL TEXT  

Radiofrequency Ablation of the Nerve to the Corrugator Muscle for Elimination of Glabellar Furrowing
Utley and Goode
Arch Facial Plast Surg 1999;1:46-48.
ABSTRACT | FULL TEXT  

An Anatomical Approach to Glabellar Rhytids
Macdonald et al.
Arch Otolaryngol Head Neck Surg 1998;124:1315-1320.
ABSTRACT | FULL TEXT  

Chemical Browlift
Frankel and Kamer
Arch Otolaryngol Head Neck Surg 1998;124:321-323.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.